![](https://bl-i.thgim.com/public/incoming/bdqdn7/article68309009.ece/alternates/LANDSCAPE_1200/IMG_pharma_companies_pha_2_1_KHAHG3QI.jpg)
With pharma stocks going strong, valuations don’t leave room for error
The pharma sector has been on a roll, with peak revenues in FY24. The Nifty Pharma breached 20,000 levels for the first time in July 2024, gaining 20 per cent YTD compared to Nifty-50’s 12 per cent gain. Pharma valuations, which have been on the rise in …